Aptose Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Aptose Biosciences Stock Summary

Aptose Biosciences competes with CytomX Therapeutics, Instil Bio, Spero Therapeutics, Assembly Biosciences, and Fortress Biotech. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada. Aptose Bioscns operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

Aptose Biosciences Key Financial Ratios

Aptose Biosciences Key Balance Sheet Accounts

Aptose Biosciences Key Income Statement Accounts

Aptose Biosciences Key Cash Accounts

Aptose Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aptose Biosciences's current stock value. Our valuation model uses many indicators to compare Aptose Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptose Biosciences competition to find correlations between indicators driving Aptose Biosciences's intrinsic value. More Info.Aptose Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Aptose Biosciences' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aptose Biosciences' earnings, one of the primary drivers of an investment's value.

Aptose Biosciences Systematic Risk

Today, most investors in Aptose Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aptose Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aptose Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Aptose Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aptose Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aptose Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Aptose Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aptose Biosciences's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.